These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6489005)

  • 1. [Mesangial IgM nephropathy].
    Zhang JH; Li LS
    Zhonghua Nei Ke Za Zhi; 1984 Mar; 23(3):141-4. PubMed ID: 6489005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicopathological study of renal biopsy cases with predominant IgM deposition with particular reference to the disease entity, IgM nephropathy].
    Maeda S; Ishihara S; Kobayashi S; Yamada A; Migita T; Kitajima W; Kobayashi K; Nishiura T; Kawamura S; Tsujimoto S
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1399-409. PubMed ID: 3820816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histologic transition in patients with minimal-change nephrotic syndrome to mesangial IgM nephropathy].
    Claros González I; Baños Gallardo M; Forascepi Roza R; Argüelles Toraño M
    Rev Clin Esp; 1986 Dec; 179(9):476-7. PubMed ID: 3809684
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence & significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood.
    Bhuyan UN; Srivastava RN
    Indian J Med Res; 1987 Jul; 86():53-60. PubMed ID: 3692560
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions.
    Hirszel P; Yamase HT; Carney WR; Galen MA; Graeber CW; Johnson KJ; Kennedy TL; Lapkin RA; McLean RH; Rosenworcel E
    Nephron; 1984; 38(2):100-8. PubMed ID: 6382035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
    Looi LM; Wang F; Lam KL; Chua CT
    Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM nephropathy: morphological study related to clinical findings.
    Kopolovic J; Shvil Y; Pomeranz A; Ron N; Rubinger D; Oren R
    Am J Nephrol; 1987; 7(4):275-80. PubMed ID: 3318460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM nephropathy in adults: incidence and correlation with electron microscopic features.
    Bhowmik D; Chitale A; Bulchand S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):511-4. PubMed ID: 17883120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
    Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.
    Lin CY; Chen CH; Lee PP
    Pediatr Nephrol; 1989 Jul; 3(3):254-8. PubMed ID: 2702103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy in children.
    Yoshikawa N; Matsuo T
    Compr Ther; 1984 May; 10(5):35-41. PubMed ID: 6375943
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of mesangial IgM nephropathy into focal segmental glomerulosclerosis.
    Jennette JC
    Am J Nephrol; 1981; 1(3-4):222. PubMed ID: 7349055
    [No Abstract]   [Full Text] [Related]  

  • 15. Callitrichid IgM-nephropathy--an old age-related disease?
    Brack M
    Lab Anim; 1995 Jan; 29(1):54-8. PubMed ID: 7707679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing minimal-change disease from mesangial disorders.
    Border WA
    Kidney Int; 1988 Sep; 34(3):419-34. PubMed ID: 3050250
    [No Abstract]   [Full Text] [Related]  

  • 17. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.
    Ji-Yun Y; Melvin T; Sibley R; Michael AF
    Kidney Int; 1984 Jan; 25(1):100-6. PubMed ID: 6727121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and treatment of immune-mediated renal disease.
    Mann R; Neilson EG
    Med Clin North Am; 1985 Jul; 69(4):715-50. PubMed ID: 3903377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric analysis in the diagnosis and differentiation of certain glomerulopathies (MCD, GNMes, FSG).
    Woźniak A; Kaczmarek E; Salwa-Zurawska W; Bortkiewicz E; Maciejewski J; Krzymański M
    Pol J Pathol; 1994; 45(3):187-93. PubMed ID: 7953435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent immunologic data on human glomerulonephritis.
    Lesavre P; Monteiro RC; Chevailler A; Berger J; Halbwachs-Mecarelli L; Noël LH
    Adv Nephrol Necker Hosp; 1988; 17():57-75. PubMed ID: 3124552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.